326 related articles for article (PubMed ID: 23874596)
1. The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase.
Jin Z; Smith LK; Rajwanshi VK; Kim B; Deval J
PLoS One; 2013; 8(7):e68347. PubMed ID: 23874596
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase.
Sangawa H; Komeno T; Nishikawa H; Yoshida A; Takahashi K; Nomura N; Furuta Y
Antimicrob Agents Chemother; 2013 Nov; 57(11):5202-8. PubMed ID: 23917318
[TBL] [Abstract][Full Text] [Related]
3. Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells.
Smee DF; Hurst BL; Egawa H; Takahashi K; Kadota T; Furuta Y
J Antimicrob Chemother; 2009 Oct; 64(4):741-6. PubMed ID: 19643775
[TBL] [Abstract][Full Text] [Related]
4. Biochemical Evaluation of the Inhibition Properties of Favipiravir and 2'-C-Methyl-Cytidine Triphosphates against Human and Mouse Norovirus RNA Polymerases.
Jin Z; Tucker K; Lin X; Kao CC; Shaw K; Tan H; Symons J; Behera I; Rajwanshi VK; Dyatkina N; Wang G; Beigelman L; Deval J
Antimicrob Agents Chemother; 2015 Dec; 59(12):7504-16. PubMed ID: 26392512
[TBL] [Abstract][Full Text] [Related]
5. Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis.
Vanderlinden E; Vrancken B; Van Houdt J; Rajwanshi VK; Gillemot S; Andrei G; Lemey P; Naesens L
Antimicrob Agents Chemother; 2016 Nov; 60(11):6679-6691. PubMed ID: 27572398
[TBL] [Abstract][Full Text] [Related]
6. Favipiravir (T-705), a novel viral RNA polymerase inhibitor.
Furuta Y; Gowen BB; Takahashi K; Shiraki K; Smee DF; Barnard DL
Antiviral Res; 2013 Nov; 100(2):446-54. PubMed ID: 24084488
[TBL] [Abstract][Full Text] [Related]
7. T-705 (favipiravir) activity against lethal H5N1 influenza A viruses.
Kiso M; Takahashi K; Sakai-Tagawa Y; Shinya K; Sakabe S; Le QM; Ozawa M; Furuta Y; Kawaoka Y
Proc Natl Acad Sci U S A; 2010 Jan; 107(2):882-7. PubMed ID: 20080770
[TBL] [Abstract][Full Text] [Related]
8. Role of human hypoxanthine guanine phosphoribosyltransferase in activation of the antiviral agent T-705 (favipiravir).
Naesens L; Guddat LW; Keough DT; van Kuilenburg AB; Meijer J; Vande Voorde J; Balzarini J
Mol Pharmacol; 2013 Oct; 84(4):615-29. PubMed ID: 23907213
[TBL] [Abstract][Full Text] [Related]
9. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase.
Furuta Y; Komeno T; Nakamura T
Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(7):449-463. PubMed ID: 28769016
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of T-705 against influenza virus.
Furuta Y; Takahashi K; Kuno-Maekawa M; Sangawa H; Uehara S; Kozaki K; Nomura N; Egawa H; Shiraki K
Antimicrob Agents Chemother; 2005 Mar; 49(3):981-6. PubMed ID: 15728892
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate.
Eriksson B; Helgstrand E; Johansson NG; Larsson A; Misiorny A; Norén JO; Philipson L; Stenberg K; Stening G; Stridh S; Oberg B
Antimicrob Agents Chemother; 1977 Jun; 11(6):946-51. PubMed ID: 879760
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the responsible site for favipiravir resistance in RNA-dependent RNA polymerase of influenza virus A/PR/8/34 (H1N1) using site-directed mutagenesis.
Komeno T; Furuta Y; Nakajima N; Tani H; Morinaga Y
Antiviral Res; 2022 Sep; 205():105387. PubMed ID: 35931138
[TBL] [Abstract][Full Text] [Related]
13. Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
Huchting J; Vanderlinden E; Winkler M; Nasser H; Naesens L; Meier C
J Med Chem; 2018 Jul; 61(14):6193-6210. PubMed ID: 29906392
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the Antiviral Potency of Nucleobases for Potential Broad-Spectrum Antiviral Therapies.
Soto-Acosta R; Edwards TC; Dreis CD; Krishna VD; Cheeran MC; Qiu L; Xie J; Bonnac LF; Geraghty RJ
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960780
[TBL] [Abstract][Full Text] [Related]
15. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of action of T-705 as a unique delayed chain terminator on influenza viral polymerase transcription.
Wang Y; Yuan C; Xu X; Chong TH; Zhang L; Cheung PP; Huang X
Biophys Chem; 2021 Oct; 277():106652. PubMed ID: 34237555
[TBL] [Abstract][Full Text] [Related]
17. T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections.
Furuta Y; Takahashi K; Shiraki K; Sakamoto K; Smee DF; Barnard DL; Gowen BB; Julander JG; Morrey JD
Antiviral Res; 2009 Jun; 82(3):95-102. PubMed ID: 19428599
[TBL] [Abstract][Full Text] [Related]
18. Characterization of susceptibility variants of poliovirus grown in the presence of favipiravir.
Daikoku T; Mizuguchi M; Obita T; Yokoyama T; Yoshida Y; Takemoto M; Shiraki K
J Microbiol Immunol Infect; 2018 Oct; 51(5):581-586. PubMed ID: 28709841
[TBL] [Abstract][Full Text] [Related]
19. Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitro.
Wray SK; Gilbert BE; Knight V
Antiviral Res; 1985 Feb; 5(1):39-48. PubMed ID: 3985607
[TBL] [Abstract][Full Text] [Related]
20. Mutagenic and inhibitory effects of ribavirin on hepatitis C virus RNA polymerase.
Vo NV; Young KC; Lai MM
Biochemistry; 2003 Sep; 42(35):10462-71. PubMed ID: 12950173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
